Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
Overview of Exosomes01:36

Overview of Exosomes

2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

4.9K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
4.9K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.9K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
Bone Cells and Tissue01:30

Bone Cells and Tissue

4.8K
Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering a skeletal muscle model to study extracellular vesicle dynamics.

Journal of tissue engineering·2026
Same author

Engineering Extracellular Vesicle Production Through Magnetic Ion Channel Activation for Bone Regeneration.

Advanced healthcare materials·2026
Same author

TNAP-positive matrix vesicles are enriched in Annexin II and tetraspanins.

Bone·2026
Same author

Extracellular vesicles may provide an alternative detoxification pathway during skeletal muscle myoblast ageing.

Journal of extracellular biology·2024
Same author

Defining the influence of size-exclusion chromatography fraction window and ultrafiltration column choice on extracellular vesicle recovery in a skeletal muscle model.

Journal of extracellular biology·2024
Same author

Editorial: Mesenchymal stem cell-derived extracellular vesicles: considerations and therapeutic applications.

Frontiers in cell and developmental biology·2024

Related Experiment Video

Updated: Aug 8, 2025

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants
07:58

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants

Published on: October 4, 2021

2.7K

Extracellular vesicles: From bone development to regenerative orthopedics.

Owen G Davies1

  • 1School of Sport, Exercise, and Health Sciences, Loughborough University, Epinal Way, Loughborough, Leicestershire LE11 3TU, UK.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|March 4, 2023
PubMed
Summary

Extracellular vesicles (EVs) show promise for regenerative medicine, particularly for skeletal defects. However, challenges in standardization, dosing, and scalable manufacturing must be overcome for clinical translation.

Keywords:
boneexosomeextracellular vesiclesmatrix vesiclemineralizationregenerative

More Related Videos

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
04:16

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants

Published on: August 5, 2021

2.4K
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
06:05

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

1.1K

Related Experiment Videos

Last Updated: Aug 8, 2025

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants
07:58

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants

Published on: October 4, 2021

2.7K
Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
04:16

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants

Published on: August 5, 2021

2.4K
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
06:05

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

1.1K

Area of Science:

  • Regenerative Medicine
  • Biotechnology
  • Tissue Engineering

Background:

  • Regenerative medicine seeks to replace damaged or diseased tissues.
  • Clinical translation of experimental regenerative therapies faces significant hurdles.
  • Extracellular vesicles (EVs) are emerging as a promising therapeutic alternative.

Purpose of the Study:

  • To review the advantages of using EVs for treating skeletal defects.
  • To outline the current state-of-the-art in EV-based regenerative therapies.
  • To identify key areas for future research and development.

Main Methods:

  • Review of current literature on extracellular vesicle applications in regenerative medicine.
  • Analysis of strategies for modulating EV production, targeting, and therapeutic potency.
  • Evaluation of material systems and implant functionalization for enhanced osseointegration.

Main Results:

  • EVs offer potential for treating skeletal defects through engineered culture environments and direct/indirect manipulation.
  • Material systems and functionalized implants show promise for modulating EV release and improving osseointegration.
  • Inconsistencies in EV nomenclature and challenges in defining a reproducible therapeutic dose were identified.

Conclusions:

  • Scalable manufacturing of therapeutically potent and pure EV products is critical.
  • Addressing challenges in cell sources and culture environments is necessary for scalable EV production.
  • Overcoming current limitations is essential for the regulatory approval and clinical translation of regenerative EV therapies.